Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Avidity Biosciences, Inc. (RNA)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| | 10-K | 10-K | 10-K | 10-K | S-1/A |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 0.0% | 0.0% | 0.0% | 0.0% | 2869.9% |
| Gross profit | 100.0% | 100.0% | 100.0% | 100.0% | -2769.9% |
| Research and development | 1630.6% | 1084.9% | 554.0% | 627.0% | |
| General and administrative | 409.1% | 280.9% | 198.3% | 220.4% | 644.1% |
| Depreciation | 15.0% | 6.9% | 5.5% | 15.0% | 101.1% |
| EBIT | -1939.6% | -1265.8% | -652.4% | -747.4% | -2769.9% |
| Pre-tax income | -1886.3% | -1265.4% | -653.5% | -1066.6% | -2959.4% |
| Income taxes | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -1886.3% | -1265.4% | -653.5% | -1066.6% | -2959.4% |
|